OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Respiratory Cell and Molecular Biology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease	126
Lung Myofibroblasts Promote Macrophage Profibrotic Activity through Lactate-induced Histone Lactylation	109
Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report	82
Applications and Approaches for Three-Dimensional Precision-Cut Lung Slices. Disease Modeling and Drug Discovery	75
A Microengineered Airway Lung Chip Models Key Features of Viral-induced Exacerbation of Asthma	74
Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges	64
Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–infected Hamsters: What Matters?	62
Extracellular Vesicles from Fibroblasts Induce Epithelial-Cell Senescence in Pulmonary Fibrosis	62
The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis	57
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging	57
Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats	54
PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung	51
Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome	48
Dose-Dependent Pulmonary Toxicity of Aerosolized Vitamin E Acetate	45
TGF-β Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation	45
Connective-Tissue Growth Factor Contributes to TGF-β1–induced Lung Fibrosis	43
Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis	43
FGFR2 Is Required for AEC2 Homeostasis and Survival after Bleomycin-induced Lung Injury	42
Regulated Necrosis in Pulmonary Disease. A Focus on Necroptosis and Ferroptosis	42
ATF4 Mediates Mitochondrial Unfolded Protein Response in Alveolar Epithelial Cells	42
Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis	41
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection	41
Electronic-Cigarette Use Alters Nasal Mucosal Immune Response to Live-attenuated Influenza Virus. A Clinical Trial	40
Metabolomics to Predict Antiviral Drug Efficacy in COVID-19	39
Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases	38

Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice	38
Single-Nucleus RNA-Sequencing Profiling of Mouse Lung. Reduced Dissociation Bias and Improved Rare Cell-Type Detection Compared with Single-Cell RNA Sequencing	37
Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α	37
Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19	37
Targeting Jak–Stat Signaling in Experimental Pulmonary Hypertension	36
Hepatocyte HIF-1 and Intermittent Hypoxia Independently Impact Liver Fibrosis in Murine Nonalcoholic Fatty Liver Disease	36
Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis	36
Blocking Notch3 Signaling Abolishes MUC5AC Production in Airway Epithelial Cells from Individuals with Asthma	35
Flow-Cytometric Analysis and Purification of Airway Epithelial-Cell Subsets	33